🇺🇸 FDA
Patent

US 9260504

N- and C-terminal substituted antagonistic analogs of GH-RH

granted A61KA61K38/00A61K38/25

Quick answer

US patent 9260504 (N- and C-terminal substituted antagonistic analogs of GH-RH) held by THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Grant date
Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00, A61K38/25, A61P, A61P35/00